MIM
SCMP

Monashee Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Monashee Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-35,000
Closed -$393K – 73
2017
Q2 		$368K Buy
+35,000
New +$357K 0.16% 75
2017
Q1 		– Sell
-35,000
Closed -$406K – 74
2016
Q4 		$474K Buy
+35,000
New +$488K 0.23% 70
2015
Q2 		– Sell
-75,000
Closed -$1.17M – 119
2015
Q1 		$1.17M Buy
+75,000
New +$1.16M 0.73% 41

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Monashee Investment Management's SCMP Position: Q3 2017 in Review

Monashee Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 35,000 shares — an estimated $393K sold.

Monashee Investment Management first reported a position in SCMP in Q1 2015 and held it in 3 quarters. The position peaked at $1.17M in Q1 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Monashee Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Monashee Investment Management sold 35,000 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $393K.
  • Monashee Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Monashee Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.17M in Q1 2015.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.